Tue, Nov 26, 2024
Volume 7, Issue 3 (Autumn 2017)
PTJ 2017, 7(3): 175-184 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Maroof V, Salavati M, Mosallanejhad Z, Nabavi S M. Comparison of Health-Related Quality of Life in Patients With Various Types of Multiple Sclerosis. PTJ 2017; 7 (3) :175-184
URL: http://ptj.uswr.ac.ir/article-1-208-en.html
URL: http://ptj.uswr.ac.ir/article-1-208-en.html
1- Department of Physiotherapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
2- Department of Internal Medicine, Faculty of Medicine, Shahed University of Medical Sciences, Tehran, Iran.
2- Department of Internal Medicine, Faculty of Medicine, Shahed University of Medical Sciences, Tehran, Iran.
Abstract: (3933 Views)
Purpose: Chronic diseases affect patients’ Quality of Life (QoL) and even their caregivers. By evaluating the QoL of patients with multiple sclerosis, the undiagnosed problems of the patients can be detected and the appropriate treatment objectives can be determined. This study was conducted to evaluate the QoL in patients with different types of MS.
Methods: A total of 314 patients with Multiple Sclerosis (MS) referred to “Society for the support of MS patients”, “Raad Charity and Education complex”, and an outpatient clinic in Tehran during fall and winter 2014-2015 were recruited. All patients completed the 36-Item Short Form questionnaire (SF-36) and Dartmouth Coop Functional Health Assessment/World Organization of National Colleges, Academies and Academic Association of General Practitioners (COOP/WONCA) functional health assessment charts as self-report.
Results: To investigate the research hypothesis and analyzing the results of the two questionnaires, 1-way analysis of variance (ANOVA) was used. The results of the analysis showed a significant difference between the three types of MS (relapsing-remitting, secondary progressive and primary progressive) in the scores of all SF-36 questionnaire subscales. A significant difference was also found between the three types of MS regarding the scores of all charts of COOP/WONCA, except for social support. Then with the use of LSD post hoc test, scores of both questionnaires subscales in these three types of MS were pair-wisely compared.
Conclusion: The results showed that the type of MS disease can affect the patients’ QoL. Patients with relapsing-remitting MS had the best level of QoL among all others. The COOP/WONCA charts were more sensitive in measuring the differences between the secondary-progressive MS and primary-progressive MS.
Methods: A total of 314 patients with Multiple Sclerosis (MS) referred to “Society for the support of MS patients”, “Raad Charity and Education complex”, and an outpatient clinic in Tehran during fall and winter 2014-2015 were recruited. All patients completed the 36-Item Short Form questionnaire (SF-36) and Dartmouth Coop Functional Health Assessment/World Organization of National Colleges, Academies and Academic Association of General Practitioners (COOP/WONCA) functional health assessment charts as self-report.
Results: To investigate the research hypothesis and analyzing the results of the two questionnaires, 1-way analysis of variance (ANOVA) was used. The results of the analysis showed a significant difference between the three types of MS (relapsing-remitting, secondary progressive and primary progressive) in the scores of all SF-36 questionnaire subscales. A significant difference was also found between the three types of MS regarding the scores of all charts of COOP/WONCA, except for social support. Then with the use of LSD post hoc test, scores of both questionnaires subscales in these three types of MS were pair-wisely compared.
Conclusion: The results showed that the type of MS disease can affect the patients’ QoL. Patients with relapsing-remitting MS had the best level of QoL among all others. The COOP/WONCA charts were more sensitive in measuring the differences between the secondary-progressive MS and primary-progressive MS.
Type of Study: Applicable |
Subject:
General
Received: 2017/02/20 | Accepted: 2017/06/10 | Published: 2017/10/1
Received: 2017/02/20 | Accepted: 2017/06/10 | Published: 2017/10/1
References
1. Miller DM, Kinkel RP. Health-related quality of life assessment in multiple sclerosis. Reviews in Neurological Diseases. 2008; 5(2):56-64. [PMID] [PMID]
2. Mitchell AJ, Benito-León J, González JMM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing. The Lancet Neurology. 2005; 4(9):556–66. [DOI:10.1016/S1474-4422(05)70166-6] [DOI:10.1016/S1474-4422(05)70166-6]
3. Miller DM, Allen R. Quality of life in multiple sclerosis: Determinants, measurement, and use in clinical practice. Current Neurology and Neuroscience Reports. 2010; 10(5):397-406. [DOI:10.1007/s11910-010-0132-4] [PMID] [DOI:10.1007/s11910-010-0132-4]
4. Ganz PA. Impact of quality of life outcomes on clinical practice. Oncology. 1995; 9(11):61-5. [PMID]
5. Solari A. Role of health-related quality of Life measures in the routine care of people with Multiple Sclerosis. Health Qual Life Outcomes. 2005; 3:16. [DOI:10.1186/1477-7525-3-16] [PMID] [PMCID] [DOI:10.1186/1477-7525-3-16]
6. Benito-León J, Manuel Morales J, Rivera-Navarro J, Mitchell AJ. A review about the impact of multiple sclerosis on health-related quality of life. Disability and Rehabilitation. 2003; 25(23):1291–303. [DOI:10.1080/09638280310001608591] [PMID] [DOI:10.1080/09638280310001608591]
7. Devins GM, Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H. Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and Multiple Sclerosis. The Journal of Nervous and Mental Disease. 1993; 181(6):377–81. [DOI:10.1097/00005053-199306000-00007] [PMID] [DOI:10.1097/00005053-199306000-00007]
8. Rudick RA, Miller D, Clough JD. Quality of life in multiple sclerosis: Comparison with inflammatory bowel disease and rheumatoid arthritis. Archives of Neurology. 1992; 49(12):1237-42. [DOI:10.1001/archneur.1992.00530360035014] [PMID] [DOI:10.1001/archneur.1992.00530360035014]
9. Benedict RHB, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. Journal of the Neurological Sciences. 2005; 231(1-2):29–34. [DOI:10.1016/j.jns.2004.12.009] [PMID] [DOI:10.1016/j.jns.2004.12.009]
10. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology. 1996; 46(4):907–11. [DOI:10.1212/WNL.46.4.907] [PMID] [DOI:10.1212/WNL.46.4.907]
11. Mortensen GL, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient preference and adherence. 2017;11:1789-96. [DOI:10.2147/ppa.s142373] [DOI:10.2147/PPA.S142373]
12. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): Translation and validation study of the Iranian version. Quality of Life Research. 2005; 14(3):875–82. [DOI:10.1007/s11136-004-1014-5] [PMID] [DOI:10.1007/s11136-004-1014-5]
13. Ware JE, Sherbourne CD. The MOS 36-ltem Short-Form Health Survey (SF-36). Medical Care. 1992; 30(6):473–83. [DOI:10.1097/00005650-199206000-00002] [PMID] [DOI:10.1097/00005650-199206000-00002]
14. Taghipoor M. [Translation, localization and evaluation of the reliability and validity of the Persian version of the COOP WONCA scale in people with multiple sclerosis Persian language Persian language (Persian)] [MSc. thesis]. Tehran: University of Social Welfare and Rehabilitation Sciences; 2013.
15. Nelson E, Wasson J, Kirk J, Keller A, Clark D, Dietrich A, et al. Assessment of function in routine clinical practice: Description of the coop chart method and preliminary findings. Journal of Chronic Diseases. 1987; 40:55S–63S. [DOI:10.1016/S0021-9681(87)80033-4] [DOI:10.1016/S0021-9681(87)80033-4]
16. Cohen J. Statistical power analysis for the behavioral sciences. New York: Routledge; 2013. [DOI:10.4324/9780203771587] [DOI:10.4324/9780203771587]
17. Drulovic J, Pekmezovic T, Matejic B, Mesaros S, Manigoda M, Dujmovic I, et al. Quality of life in patients with multiple sclerosis in Serbia. Acta Neurologica Scandinavica. 2007; 115(3):147–52. [DOI:10.1111/j.1600-0404.2006.00729.x] [PMID] [DOI:10.1111/j.1600-0404.2006.00729.x]
18. Gottberg K, Einarsson U, Ytterberg C, de Pedro Cuesta J, Fredrikson S, von Koch L, et al. Health-related quality of life in a population-based sample of people with Multiple Sclerosis in Stockholm County. Multiple Sclerosis Journal. 2006; 12(5):605–12. [DOI:10.1177/1352458505070660] [PMID] [DOI:10.1177/1352458505070660]
19. Patti F, Russo P, Pappalardo A, Macchia F, Civalleri L, Paolillo A. Predictors of quality of life among patients with multiple sclerosis: An Italian cross-sectional study. Journal of the Neurological Sciences. 2007; 252(2):121–9. [DOI:10.1016/j.jns.2006.10.017] [PMID] [DOI:10.1016/j.jns.2006.10.017]
20. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis. Journal of the Neurological Sciences. 2002; 205(1):51–8. [DOI:10.1016/S0022-510X(02)00312-X] [DOI:10.1016/S0022-510X(02)00312-X]
21. Beiske AG, Baumstarck K, Nilsen RM, Simeoni M-C. Validation of the Multiple Sclerosis International Quality of Life (MusiQoL) questionnaire in Norwegian patients. Acta Neurologica Scandinavica. 2011; 125(3):171–9. [DOI:10.1111/j.1600-0404.2011.01518.x] [PMID] [DOI:10.1111/j.1600-0404.2011.01518.x]
22. Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Social Science & Medicine. 1999; 48(8):977–88. [DOI:10.1016/S0277-9536(98)00411-0] [DOI:10.1016/S0277-9536(98)00411-0]
23. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, et al. Quality of Life Is favorable for most patients with Multiple Sclerosis. Archives of Neurology. 2004; 61(5):679-86. [DOI:10.1001/archneur.61.5.679] [PMID] [DOI:10.1001/archneur.61.5.679]
24. Murray TJ. The psychosocial aspects of Multiple Sclerosis. Neurologic Clinics. 1995; 13(1):197–223. [DOI:10.1016/S0733-8619(18)30067-7] [DOI:10.1016/S0733-8619(18)30067-7]
25. Ford HL, Gerry MH, Johnson AH. Health status and quality of life of people with Multiple Sclerosis. Disability and Rehabilitation. 2001; 23(12):516–21. [DOI:10.1080/09638280010022090] [PMID] [DOI:10.1080/09638280010022090]
26. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in Multiple Sclerosis. New England Journal of Medicine. 2000; 343(20):1430–8. [DOI:10.1056/NEJM200011163432001] [PMID] [DOI:10.1056/NEJM200011163432001]
27. Simeoni M, Auquier P, Fernandez O, Flachenecker P, Stecchi S, Constantinescu C, et al. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis Journal. 2007; 14(2):219–30. [DOI:10.1177/1352458507080733] [PMID] [DOI:10.1177/1352458507080733]
28. Fernández O, Fernández V, Baumstarck-Barrau K, Mu-oz L, Gonzalez Alvarez M del M, et al. Validation of the Spanish version of the multiple sclerosis international quality of life (musiqol) questionnaire. BMC Neurology. 2011; 11:127. [DOI:10.1186/1471-2377-11-127] [PMID] [PMCID] [DOI:10.1186/1471-2377-11-127]
29. Patti F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D, et al. Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. Journal of the Neurological Sciences. 2003; 211(1-2):55–62. [DOI:10.1016/S0022-510X(03)00040-6] [DOI:10.1016/S0022-510X(03)00040-6]
30. Pfennings L, Cohen L, Adèr H, Polman C, Lankhorst G, Smits R, et al. Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. Journal of Neurology. 1999; 246(7):587–91. [DOI:10.1007/s004150050408] [PMID] [DOI:10.1007/s004150050408]
31. Merkelbach S, Sittinger H, Koenig J. Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis? The Journal of Nervous and Mental Disease. 2002; 190(6):388–93. [DOI:10.1097/00005053-200206000-00007] [PMID] [DOI:10.1097/00005053-200206000-00007]
32. Benito-Leon J, Morales JM, Rivera-Navarro J. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. European Journal of Neurology. 2002; 9(5):497–502. [DOI:10.1046/j.1468-1331.2002.00450.x] [PMID] [DOI:10.1046/j.1468-1331.2002.00450.x]
33. Ghaem H, Haghighi AB, Jafari P, Nikseresht A. Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire. Neurology India. 2007; 55(4):369. [DOI:10.4103/0028-3886.33316] [PMID] [DOI:10.4103/0028-3886.33316]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
